118 related articles for article (PubMed ID: 37640002)
21. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.
Dong W; Zhao L; Zhang S; Zhang S; Si H
World J Surg Oncol; 2021 Mar; 19(1):75. PubMed ID: 33715625
[TBL] [Abstract][Full Text] [Related]
22. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
Wang J; Fang Y; Liu T
Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
[TBL] [Abstract][Full Text] [Related]
23. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
24. Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression.
Hei N; Liu P; Jin L; Peng S; Bao Y
Funct Integr Genomics; 2023 Jan; 23(1):52. PubMed ID: 36717528
[TBL] [Abstract][Full Text] [Related]
25. Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation.
Zhou W; Feng Y; Lin C; Chao CK; He Z; Zhao S; Xue J; Zhao XY; Cao W
Adv Sci (Weinh); 2023 Sep; 10(25):e2207549. PubMed ID: 37401236
[TBL] [Abstract][Full Text] [Related]
26. Circ_0001971 makes progress of oral squamous cell carcinoma by targeting miR-107/FZD4 axis.
Lu X; Xie H
Oral Dis; 2023 Jul; 29(5):1979-1990. PubMed ID: 35403775
[TBL] [Abstract][Full Text] [Related]
27. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
29. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
30. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
[TBL] [Abstract][Full Text] [Related]
31. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
[TBL] [Abstract][Full Text] [Related]
32. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Yin H; Li Z; Chen J; Hu X
J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
[TBL] [Abstract][Full Text] [Related]
33. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
34. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.
Wu Z; He X; Chen S
Braz J Med Biol Res; 2021; 54(10):e10837. PubMed ID: 34287578
[TBL] [Abstract][Full Text] [Related]
36. CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p.
Lu Q; Che H; Che Y; Hu M
Clin Transl Oncol; 2023 Jun; 25(6):1690-1701. PubMed ID: 36635458
[TBL] [Abstract][Full Text] [Related]
37. PDIA6 contributes to aerobic glycolysis and cancer progression in oral squamous cell carcinoma.
Mao L; Wu X; Gong Z; Yu M; Huang Z
World J Surg Oncol; 2021 Mar; 19(1):88. PubMed ID: 33761940
[TBL] [Abstract][Full Text] [Related]
38. Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
Zhou X; Xue D; Qiu J
Head Neck; 2022 Jan; 44(1):89-103. PubMed ID: 34713497
[TBL] [Abstract][Full Text] [Related]
39. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
40. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
